STEINERT DISEASE
Clinical trials for STEINERT DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEINERT DISEASE trials appear
Sign up with your email to follow new studies for STEINERT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to ease muscle symptoms in myotonic dystrophy
Disease control Recruiting nowThis study tests a new medicine, DYNE-101, in 150 adults with myotonic dystrophy type 1, a condition that causes muscle weakness and stiffness. Participants will receive either the drug or a placebo for 48 weeks to see if it improves muscle function and daily activities. The goal…
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
Massive spanish DM1 registry aims to unlock disease secrets
Knowledge-focused Recruiting nowThis study is creating a large national registry in Spain for people with Myotonic Dystrophy Type 1 (DM1), a rare genetic muscle disease. Researchers will collect medical information, genetic data, and patient reports from up to 3,000 participants. The goal is to better understan…
Matched conditions: STEINERT DISEASE
Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Knowledge-focused
Last updated May 17, 2026 05:29 UTC